Osteoclasts, the only bone-resorbing cells, are central to the pathogenesis of osteoporosis, yet their development and regulation are incompletely understood. Multiple receptors of the immune system use a common signaling paradigm whereby phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) within receptor-associated adapter proteins recruit the Syk tyrosine kinase. Here we demonstrate that a similar mechanism is required for development of functional osteoclasts. Mice lacking two ITAM-bearing adapters, DAP12 and the Fc receptor ␥-chain (FcR␥), are severely osteopetrotic. DAP12 ؊/؊ FcR␥ ؊/؊ bone marrow cells fail to differentiate into multinucleated osteoclasts or resorb bone in vitro and show impaired phosphorylation of the Syk tyrosine kinase. syk ؊/؊ progenitors are similarly defective in osteoclast development and bone resorption. Intact SH2-domains of Syk, introduced by retroviral transduction, are required for functional reconstitution of syk ؊/؊ osteoclasts, whereas intact ITAMdomains on DAP12 are required for reconstitution of DAP12 ؊/؊ FcR␥ ؊/؊ cells. These data indicate that recruitment of Syk to phosphorylated ITAMs is critical for osteoclastogenesis. Although DAP12 appears to be primarily responsible for osteoclast differentiation in cultures directly stimulated with macrophage-colony stimulating factor and receptor activator of NF-B ligand cytokines, DAP12 and FcR␥ have overlapping roles in supporting osteoclast development in osteoblast-osteoclast cocultures, which mirrors their overlapping functions in vivo. These results provide new insight into the biology of osteoclasts and suggest novel therapeutic targets in diseases of bony remodeling. O steoclasts are derived from hematopoietic precursor cells of the myeloid lineage. Although signals through the receptor activator of NF-B (RANK)͞RANKL (RANK ligand) and colonystimulating factor 1 receptor͞macrophage-colony-stimulating factor (M-CSF) receptor͞ligand pairs are clearly required for osteoclastogenesis, regulation by other receptor-mediated signals is less well defined (1) . Immunoreceptor tyrosine-based activation motif (ITAM)-mediated signaling is critical for receptors of the adaptive immune system (B cell receptors, T cell receptors, and Fc receptors), and innate immune receptors that couple to the ITAMadapter proteins DAP12 and Fc receptor ␥-chain (FcR␥) also regulate cellular differentiation and function in myeloid cells (2) (3) (4) . The association of DAP12 deficiency with a human disease involving bony abnormalities (Nasu-Hakola disease or polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy) suggests that these receptors may play important roles in osteoclasts as well (5) . In both humans and mice, loss of the DAP12 ITAM signaling adapter results in a significant defect in differentiation of osteoclast-like cells (OCLs) in cell culture (6-10) but does not completely block osteoclastogenesis in vivo. This observation suggests that other ITAM signaling adapter proteins, such as FcR␥, may also be involved in osteoclastogenesis. DAP12 and FcR␥ are both transmembrane adapter proteins with ITAM domains that couple to downstream pathways through the Syk tyrosine kinase (4, 11) . Thus, we studied mice doubly deficient in DAP12 and FcR␥ and examined the functional role of Syk in osteoclasts.
Materials and Methods
Mice. We used offspring of DAP12 C57BL͞6 parents (13) was used for bone marrow transplantation as described (14) .
Micro-Computed Tomography (CT) Analysis. Proximal tibias were scanned by high resolution micro-CT (CT-20, Scanco Medical, Bassersdorf, Switzerland) with a cubic voxel size of 9 m and with 3D structural parameters calculated (15, 16 ) (see Supporting Methods, which is published as supporting information on the PNAS web site). Groups were compared by a nonparametric Kruskal-Wallis with Dunn's post hoc test (INSTAT, GraphPad, San Diego).
Histologic Analysis and Immunofluorescence Microscopy. Proximal tibias were fixed in PBS plus 4% paraformaldehyde, decalcified in 0.5 M EDTA (pH 7.4), paraffin-embedded, sectioned at 6 m, and stained by using standard techniques. Immunostaining was performed by using anti-Syk antibody (N-19, Santa Cruz Biotechnology), followed by Alexa Fluor-488-secondary antibody (Molecular Probes) and counterstaining with rhodamine-phalloidin.
In Vitro Osteoclast Cultures and Resorption Assays. These assays were performed as described (10) . Briefly, nonadherent bone marrow cells after 48 h in complete ␣-MEM (Invitrogen) with 10 ng͞ml murine M-CSF (osteoclast precursors) were plated at 0.5 million per cm 2 and cultured 4-7 d in 70 ng͞ml RANKL and 10 or 100 ng͞ml M-CSF (R & D Systems). Tartrate resistant acid phosphatase (TRAP) staining was performed with a commercial kit (catalog no. 387-A, Sigma). For resorption assays, osteoclast precursors were plated on BioCoat Osteologic slides (BD Biosciences) or dentine discs (Immunodiagnostic Systems, Tyne and Wear, England), and cultured with RANKL͞M-CSF for 10 d as described (10) . Groups were compared by one-way ANOVA analysis with mice develop teeth, distinguishing their phenotype from Src-or RANKL-deficient animals (18, 19) . We confirmed the osteopetrotic phenotype by micro-CT analysis of the proximal tibia (Fig. 1A) . DAP12
mice had a relative bone volume of 88 Ϯ 3% (n ϭ 4), whereas wild-type mice averaged 15 Ϯ 2% (n ϭ 3) (P Ͻ 0.001). DAP12
tibias showed markedly increased trabecular number, trabecular thickness, and decreased trabecular separation compared with wild type. The marked negative value of the structure model index (SMI) in the DAP12
mice (SMI ϭ Ϫ17.6 Ϯ 4.1) indicates an overwhelmingly concave structure, solid with tube-like channels of marrow space, rather than the rod-like trabecular structure in wild-type animals (SMI ϭ 1.7 Ϯ 0.1). Parameters from bones of FcR␥ Ϫ/Ϫ animals (n ϭ 3) did not differ from wild type, whereas DAP12 Ϫ/Ϫ mice demonstrated marginally increased bone mass (n ϭ 2), as described (8, 10) . Histological examination of DAP12
bones showed large areas of unresorbed bone with cartilagenous streaks and small bone marrow cavities in comparison with those from wild-type, DAP12
Syk Colocalizes with Actin in Osteoclasts and Fails to Be Phosphorylated in DAP12 ؊/؊ FcR␥ ؊/؊ Cells. In other cells, phosphorylation of ITAM tyrosines recruits and activates Syk through binding to its SH2 domains (2, 3, 11) . We found that Syk is expressed in wild-type OCLs generated by 70 ng͞ml RANKL and 10 ng͞ml M-CSF in vitro, and it colocalizes with actin at the cell periphery ( Fig. 2A) . OCLs express a significantly higher amount of Syk than macrophages (Fig. 2B) . By using a GST fusion protein containing the tandem SH2 domains of Syk [GST-Syk(SH2) 2 ], we show that Syk (Fig. 2E) , suggesting that FcR␥ can partially compensate for the lack of DAP12 in maintaining Syk kinase activity in OCLs.
DAP12, FcR␥, and Syk Are Required for in Vitro Generation of
Osteoclasts. In concert with the severe osteopetrosis in DAP12
osteoclast precursors showed defective in vitro osteoclast differentiation (Fig. 3A) . DAP12 (Fig. 3A) . OCLs failed to digest an artificial calcium phosphate substrate and formed barely detectable pits on dentin (Fig. 4) . In cultures with high-concentration M-CSF with partially restored TRAP ϩ multinucleated cell formation, resorption on calcium phosphate substrate by DAP12 Ϫ/Ϫ , DAP12 Ϫ/ ϪFcR␥ Ϫ/Ϫ , and syk Ϫ/Ϫ OCLs was still minimal (Fig. 4A) , suggesting that the ITAM signaling pathway may play a role in functional 
SH2 Domains of Syk are Required for Osteoclast Development and
Mineralized Matrix Resorption. Recruitment of Syk to ITAM domains depends on the binding of its SH2 domains to phosphorylated tyrosines within the ITAM. In other cell types, the R194 residue in the distal SH2 domain of Syk is critical for ITAMmediated signaling (22) . We examined the effect of this mutation in osteoclastogenesis by using retroviral expression of wild-type and R194A Syk in syk (Fig. 5 A and B) . Although numbers of OCLs formed from syk-transduced syk Ϫ/Ϫ cells remained lower than those in wild-type cell cultures, the difference correlated with lower expression levels of Syk in the retrovirally reconstituted samples (Fig. 5C ) and the efficiency of retroviral transduction (30-40% as assessed by GFP expression; data not shown). Importantly, an SH2 domain mutant (R194A) of Syk that fails to bind to phosphorylated ITAM-containing chains did not reconstitute either phenotype or resorbing function of syk
OCLs when expressed at levels equivalent to the retrovirally reconstituted wildtype Syk. These data indicate that Syk function in osteoclast formation requires SH2-phosphotyrosine binding.
Reintroduction of Intact DAP12 ITAM Is Required for Development and
Function of DAP12 ؊/؊ FcR␥ ؊/؊ Osteoclasts. We similarly examined the requirement for phosphorylated tyrosines within the DAP12 ITAM for in vitro osteoclastogenesis. Reconstitution of wild-type mouse DAP12 but not single tyrosine (Y65 or Y76) or double tyrosine (Y65͞Y76) ITAM mutants can partially restore the formation (Fig. 5D ) and resorptive function ( (Fig. 5F ). These results indicate that DAP12 is critical for osteoclastogenesis in vitro through phospho-ITAM-mediated recruitment of SH2 domain-containing proteins. (Fig. 6A) , and these OCLs resorbed an artificial bone matrix, although less than did wildtype OCLs (Fig. 6B) 
Discussion
These studies suggest a critical role for ITAM signals through the Syk tyrosine kinase during osteoclastogenesis and further illustrate the importance of this signaling pathway in the differentiation of hematopoietic cells toward highly specialized functions. ITAMmediated signals dependent on Syk kinase or the related kinase ZAP-70 are known to play essential roles in the development and function of the adaptive immune system, particularly in T cells and B cells (2) . The importance of ITAM-dependent receptors is also recognized in innate immune cells, including macrophages, neutrophils, dendritic cells, natural killer cells, and mast cells (2, 3, 14, 23) . Syk may play a broader role in cellular regulation in that it can be directly activated through ligation of surface integrins and has been shown to be critical for specific integrin-mediated functions in macrophages, neutrophils, and platelets (14, 24, 25 ). Recent find- ings that Syk is associated with a modified ITAM in ERM (ezrin, radixin, and moesin) proteins has also suggested its role in the cytoskeletal changes mediated by these proteins (26) .
In the developing osteoclast, Syk may contribute to several of these pathways, given the importance of integrins and cytoskeletal rearrangements that take place during osteoclastogenesis (1, 27) . The finding that the in vitro developmental defect but not the bone-resorbing capacity of OCLs from DAP12 preosteoclasts phosphorylated extracellular response kinase normally in response to M-CSF (data not shown), demonstrating that other signaling pathways are intact. The degree to which the deficiency of DAP12, FcR␥, or Syk directly affects ␣ V ␤ 3 integrin function in osteoclasts has not been fully explored. Syk-deficient neutrophils, macrophages, and platelets have been reported to show impaired signaling through integrins (14, 24, 25, 28) , and Syk can associate with the cytoplasmic domain of integrin ␤-chains (28). Supporting our hypothesis that ITAM signaling is linked to integrins, Faccio et al. (9) recently reported that DAP12 Ϫ/Ϫ OCLs fail to migrate to osteopontin, an ␣ V ␤ 3 integrin ligand, whereas syk Ϫ/Ϫ OCLs fail to phosphorylate Pyk2 or Src on adherence to osteopontin. Thus, it is possible that ITAM adapters may couple to cell surface integrins to provide osteoclast differentiation signaling through Src-family and Syk kinases. Such signaling likely cooperates with RANK and M-CSF receptor to provide optimal differentiation responses. Signals downstream of Syk (Cbl and Pyk2) (14) have been identified in osteoclast formation and function (21, (29) (30) (31) . ITAM signaling in other cells also stimulates phospholipase C␥ and Ca 2ϩ -flux (2, 11) , leading to activation of nuclear factor of activated T cells transcription factors (NFAT). Signaling through intracellular pathways involving NFATc1 are also required during osteoclast differentiation (32) . Interestingly, despite the clear defect in differentiation in development and function observed in DAP12 Ϫ/Ϫ , DAP12
, and syk Ϫ/Ϫ OCLs, we found that they express markers traditionally associated with late-stage differentiated osteoclasts, including calcitonin receptor, integrin ␤3, and OSCAR. Faccio et al. reported that DAP12 Ϫ/Ϫ OCLs had reduced expression of osteoclast markers at low concentrations of M-CSF at days 2 and 4 of culture (9) . Our examination of DAP12 Ϫ/Ϫ OCL at day 7 of culture did not show precursors, suggesting that FcR␥ is able to compensate for the lack of DAP12 in the presence of OB. A possible scenario could be that OB promote osteoclastogenesis by a mechanism requiring FcR␥ in osteoclasts (through, for example, the recently described OSCAR receptor, which is expected to associate with FcR␥). Such compensation may occur in vivo and explain the nearly normal bone density and the presence of multinuclear osteoclasts in DAP12 Ϫ/Ϫ mice in vivo (8, 10) . osteoclasts may allow a level of in vivo bone resorption sufficient for nearly normal bone density, even in the absence of additional signals from OB. An FcR␥-dependent signal may also originate from other (nonosteoblastic) components of the bony microenvironment (e.g., stromal cells and soft tissue matrix) that are not present in vitro. Additionally we have not ruled out that the lack of both DAP12 and FcR␥ could lead to increased bone formation by OB, exacerbating the in vivo phenotype.
Although our study demonstrates the importance of the DAP12 and FcR␥ adapter proteins in osteoclast development and function, the full spectrum of associated receptors and their ligands has not been completely defined. It is likely that, similar to other innate immune cells, osteoclasts express a number of different receptors and associated ITAM-containing signaling adapters, which provide a diverse means of regulating osteoclastogenesis in response to local changes and cellular interactions. Differences in receptor or adapter expression between mice and humans likely explain the different phenotypic consequences of DAP12 deficiency between species. The identification of the receptor͞ligand interactions involved will be critical to identifying the role of these receptors and adapters in normal and pathological bony remodeling.
Osteoporosis has been linked to dysregulation of osteoclast function, placing this cell type in the center of pathogenesis of the disease. The signaling proteins and molecular interactions described here may provide novel therapeutic approaches for the pharmacological treatment of osteoporosis or other diseases involving bony remodeling. Small molecule inhibitors of Syk are already in development for use in treatment of allergic diseases. Our results may suggest their possible utility in bone diseases.
